Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31...